Here, we give an overview of why the post-translational modifications (PTMs) of tau are often touted to be one of the main drivers of tau aggregation in tauopathies, with a large focus on the incidence of tau hyper-phosphorylation [2,4,134,135]. The gene discussed is MAPT; the disease is tauopathy.